Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
BML-277 CAS:516480-79-8
BML-277
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1409 | 100mg | 425.00 | + Add to cart |
|
| R-C-1409 | 200mg | 725.00 | + Add to cart |
|
| R-C-1409 | 500mg | 1390.00 | + Add to cart |
|
|
|
||||
Product description
Chk2 Inhibitor II(BML-277)is an ATP-competitive inhibitor of Chk2 with IC50 of 15 nM.It is 1000-fold more selective toward Chk2 serine/threonine kinase than for Chk1 and Cdk1/B kinases.Chk2 Inhibitor II(BML-277)dose dependently protects human CD4(+)and CD8(+)T-cells from apoptosis due to ionizing radiation.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---BML-277 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
